Iglesias PO, Cuello BEJ, Hechavarria MA, Ramón JM

Language: Spanish
References: 10
Page: 490-509
PDF size: 206.04 Kb.

ABSTRACT

Atrial fibrillation is the most frequent sustained dysrhythmia of the past century; In order to characterize the risk of recurrence of atrial fibrillation and its relationship with cardiac structural remodeling, a descriptive study of a series of cases was conducted at the Vladimir Ilich Lenin Hospital in 2017. The analysis of the referred information 100 patients diagnosed with atrial fibrillation identified the following results: of the patients studied, 41 (54.7%) were female and over 55 years old; the indicators of the prognostic index prevailed in the high risk of recurrence; the risk of high recurrence in mitral valvelets with predominance of mitral stenosis reached 40.7% of patients, as well as dilation of the left atrium in this same group, with a total of 22 patients (81.4%). A total of 15 patients, who represented 55.6%, had a decreased left ventricular ejection fraction with a high risk of recurrence. The highest percent of patients presented a significant and very significant p value; and finally, 22% of the patients with high risk of recurrence presented structural cardiac remodeling. It was concluded that the studied condition predominated in patients over 55 years old, female, with a high risk of recurrence in relation to the indicators of the prognostic index and predictors of structural remodeling, which justifies the alternative hypothesis, with a high clinical value and statistical.

REFERENCES

1. Gaynor SL, Schuessler RB, Bailey MS, Boineau JP, Cox JL, Damiano RJ. Surgical treatment of atrial fibrillation: Predictors of late currence. J Thorac Cardiovasc Surg 2005; 129(1): 104-11.

2. Torres Iturralde P, Lara Vaca S, Cordero Cabra A, Nava Townsend S, Celso Mendoza, Saucedo Sánchez N, et al. Diseño de un registro multicéntrico para evaluar control de ritmo contra control de la frecuencia en fibrilación auricular. Arch Cardiol Mex 2011; 81(1):13-17.

3. Montero Rincón GA. Prevención primaria en fibrilación auricular. Rev Colomb Cardiol 2016; 23(Supl 5): 186-91.

4. Levy S, Breithardt R. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 2011; 19(9): 1294-320.

5. Pava Molano LF, Perafán Bautista PE. Generalidades de la fibrilación auricular. Rev Col Cardiol 2016; 23(Supl 5): 5-8.

6. Álvarez Ortíz A. Rol del sistema autonómico y la fibrilación auricular. Rev Col Cardiol 2016; 23(Supl 5): 15-18.

7. Fibrilación Auricular. Mayo Clinic. [Internet]. 2018 [citado 25/8/2018]. Disponible en: https://www.mayoclinic.org/es-es/diseases-conditions/atrial-fibrillation/symptoms-causes/syc-20350624

8. Marsal Martín D, Rodríguez Padial L. Etiología y prevención de la fibrilación auricular. Rev Esp Cardiol 2016; 16(A): 8-11.

9. Prieto S, Young P, Cerecetto JM, Bullorsky EO. Terapia anticuagulante en fibrilación auricular. Medicina 2011; 71: 274-282.

10. Forero Gómez JE, Milena Moreno J, Agudelo CA, Rodríguez Arias CA, Sánchez Moscoso CA. Fibrilación Auricular: enfoque para el médico no cardiólogo. Latreia 2017; 30(4): 404-422.